We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breast Cancer Histopathology Employs Infrared Spectroscopic Imaging

By LabMedica International staff writers
Posted on 19 Apr 2021
Digital analysis of cancer specimens using spectroscopic imaging coupled to machine learning is an emerging area that links spatially localized spectral signatures to tissue structure and disease. More...
Breast histopathology, as an example of the broad relevance of these techniques, is critically important for clinical diagnoses.

Current histologic characterization is morphology-based; thin tissue sections are stained, and cells are visually recognized by a pathologist using an optical microscope. However, the basis of the disease is well known to be molecular. Molecular analysis for pathology is complicated by the spatial diversity of cells and acellular materials, necessitating an analytical technique that involves imaging.

Bioengineers at the University of Illinois at Urbana−Champaign (Urbana, IL, USA) and their colleagues examined the role of spatial-spectral tradeoffs in infrared spectroscopic imaging configurations for probing tumors and the associated microenvironment profiles at different levels of model complexity. The imaged breast tissue using standard and high-definition Fourier Transform Infrared (FT-IR) imaging and systematically examine the localization, spectral origins, and utility of data for classification.

The team obtained formalin-fixed, paraffin-embedded serial breast tissue microarrays (TMA) sections. The array consisted of a total of 101 cores of 1 mm diameter from 47 patients. Two sections were stained with hematoxylin and eosin (H&E) and other immunohistochemical markers and imaged with a light microscope. High-definition (HD) FT-IR imaging was conducted using the Agilent Stingray imaging system (Santa Clara, CA, USA) which is comprised of a 680-IR spectrometer coupled to a 620-IR imaging microscope with 0.62 numerical aperture, 25×objective.

The scientists provided a systematic comparison in the use of HD and SD FT-IR imaging data for breast pathology in their study. While the increased spatial localization of spectral signals in HD imaging may have been expected to provide a confounding influence, the study demonstrated that accuracy can be high, and there is significant potential in this sampling mode offering higher sensitivity. The team stated that IR imaging can not only provide the recognition capability of molecular data but can also balance that with an increased quality of morphologic data.

Rohit Bhargava, PhD, bioengineering professor and senior author of the study, said, “As technology expands and provides more capabilities with new features, it becomes more difficult to choose the optimal technology from the many options available. This study provides a nice comparison and guidelines to design a more useful and practical technology.” The study was originally published on February 27, 2021 in the journal Clinical Spectroscopy.

Related Links:
University of Illinois at Urbana−Champaign


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.